26.11.2012 Views

Peptide-Based Drug Design

Peptide-Based Drug Design

Peptide-Based Drug Design

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Analysis of Aβ Interactions 79<br />

4. Centrifuge for 1 min at 13,000 rpm and combine 100 �L of 100% saturated CHCA<br />

with 100 �L of 50% ACN, 0.5% TFA to make 200 �L of 50% saturated CHCA.<br />

Prepare CHCA in an opaque tube as it is light sensitive.<br />

5. Load 1 �L of 50% CHCA to each spot and allow to air-dry. Repeat this step,<br />

ensuring spots are dry before addition of the second layer of CHCA (see Note 8).<br />

6. See Fig. 2 for a summary of the A� capture assay.<br />

3.1.2.5. DATA ACQUISITION SETTINGS<br />

Laser and sensitivity settings need to be optimized for each new set of experimental<br />

conditions. Excess laser energy will generate flat-topped broad peaks<br />

Fig. 2. Capture of A� using Ab-coated ProteinChip arrays. Preactivated arrays with<br />

exposed active sites are shown in (A). Ab are covalently bound to the array via amine<br />

groups (B). Exposed active sites are blocked using Tris-containing buffer (C). Samples<br />

are added to the array, incubated for 1–4 h (D), and washed to remove nonspecifically<br />

bound proteins (E). EAM is applied to each spot (F), and the array is introduced into the<br />

ProteinChip reader where the laser is fired onto the chip surface. Proteins retained on<br />

the array surface are subsequently resolved via TOF-MS, which displays the mass-tocharge<br />

value and signal intensities of each protein (G, H). (Adapted from ProteinChip<br />

technology training course, Bio-Rad Laboratories.)

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!